Early Bird Special in Effect thru January 16, 2026. Details Below!
We would also like to thank the following companies who support the Dr. Walter Grand Neurosurgical Forum as an exhibitor.
From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, Abbott's purpose is to make the world a better place by bringing life-changing health technologies to the people who need them.
Boston Scientific’collaborates with healthcare professionals to develop a broad portfolio of meaningful innovations that improve outcomes, reduce costs, increase efficiencies and most importantly help more people in more places around the world live longer, healthier lives.
Cerapedics is a global leader in commercial-stage ortho-biologics and aspires to transform the standard of care for bone repair, healing bones faster and at higher rates, without compromising safety, so that patients can live their healthiest lives. Bone grafts, including Cerapedics’ products, are used in over four million annual spine, orthopedics, trauma and interventional procedures world-wide.
GammaTile is a Surgically Targeted Radiation Therapy (STaRT) for operable brain tumors that provides immediate radiation treatment after tumor removal. Each GammaTile has radiation sources embedded in a collagen tile that deliver a precise dose of radiation focused right where it is needed and away from healthy brain tissue. In a clinical study, this resulted in nearly twice as many tumor-free months compared to the patients’ most recent prior same-site treatment.[1] Watch this animation to learn how GammaTile targets brain tumors.
Integra LifeSciences (Integra) was founded to expand access to promising technology that enables the body to regenerate damaged or diseased tissue and has revolutionized the field of regenerative medicine becoming a leading global provider of neurosurgical solutions, regenerative technologies, and surgical instrumentation.
From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions. We provide our customers with innovative digital tools for managing their business that include the use artificial intelligence (AI) to support insurance billing. We have regional headquarters in the United States, Iceland, and Germany with 525 employees including a 230-person US salesforce.
KLS Martin has developed a revolutionary method for cranial and maxillofacial osteosynthesis. Zurich Cranial Distractor. Expanding possibilities in cranial vault solutions. The cranial distractor is specifically designed for controlled osteogenesis in cranial bone.
Mainstay Medical offers therapeutic solutions for adults suffering from chronic pain and aims on transforming patient lives everyday by alleviating pain and improving function by delivering a restorative therapy for mechanical Chronic Low Back Pain (CLBP) designed to change patients’ lives.
Medtronic is a global leader in healthcare technology, offering solutions for hypertension, chronic pain, cancer and more — boldly attacking the most challenging health problems facing humanity with innovations that transform lives.
Penumbra offers differentiated solutions for neurovascular access, stroke revascularization, neuro embolization, and neurosurgical evacuation.
We are a leader in the neuroendovascular field with over 3,700 global Associates across various disciplines, united by our slogan, "Game-changing impact." Unlike other companies that focus on incremental improvements, we develop transformative innovations that advance physician practice and patient outcomes. Founded in 1997, we initially focused on medical devices for small blood vessels and later specialized in aneurysm therapy with neuroendovascular platinum coils. Since joining Terumo® Corporation in 2006, we have expanded to offer 32 products, including technologies for treating ischemic stroke, carotid artery disease, and neurovascular malformations.
We would like to gratefully acknowledge all those who have supported the Dr. Walter Grand Neurosurgical Forum, Inc. non-profit organization in the past year.
Dr. Lisa Apfel
Mr. and Mrs. Laura and Bob Bartels
Dr. Amade Bregy
Dr. Jaime Calzada
Dr. Shahed Elhamdani
Dr. Andrew Fabiano
Dr. John Fahrbach
Dr. Robert Fenstermaker
Dr. W. David Freeman
Dr. Todd Fuger
Dr. Laura Grand
Yvonne Grand
Dr. Julie Hammack
Dr. Ricardo Hanel
Dr. Regis Hoppenot
Dr. Patrick Jowdy
Dr. Giuseppe Lanzino
Ms. Amy Leonardo
Dr. Jody Leonardo
Dr. Eric Nottmeier
Dr. Stephen Pirris
Dr. Rob and Aggie Plunkett
Dr. Ron Reimer
Dr. Eric Sauvageau
Chris Shaefer
Dr. Mike Springer
Dr. Rabih & Hauda Tawk
Dr. Alex Yu on behalf of Catalina, Dana & Alex
Dr. Junici Yammamoto
The Walter Grand Neurosurgery Forum is greatful to our partner AHN for offering CME credit to this years attendees.
Accreditation and Designation Information:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint providership of Allegheny General Hospital and the Dr. Walter Grand Neurosurgical Forum. Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Allegheny General Hospital designates this live activity for a maximum 10.5 AMA PRA Category 1 Credits TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.